Lymphoedema Diagnostics Market: By Technology (X-ray Lymphography, Lymphoscintigraphy, Computed Tomography, Ultrasound Imaging, Magnetic Resonance Imaging, Bioimpedance Analysis, Near-infrared Fluorescence Imaging, ICG Lymphography, Fluorescein Sodium Micro lymphangiography), By Disease Type (Cancer, Cardiovascular Disease, Inflammatory Diseases, Other Diseases), By End User (Hospitals, Diagnostic Centers, Research & Academic Institutes, Other End Users) and Geography                      

Purchase Option

$ 4400
$ 6600
$ 8900

Frequently Asked Questions

The lymphedema diagnostics market would grow at a CAGR of 7.8%.

2023 to 2029 is the growth period of the lymphedema diagnostics market.

The key driver for the lymphedema diagnostics market is the high prevalence of lymphedema and cancer, which are liable to impact the development of the lymphedema diagnostics industry optimistically.

North America is the fastest-growing regional market for the lymphedema diagnostics market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • Canon, Inc.
  • Curadel, LLC
  • Esaote SPA
  • Fluoptics
  • GE Healthcare
  • Hitachi, Ltd.
  • Impedimed Limited
  • Mindray Medical International Limited
  • Mitaka Usa, Inc.
  • Neusoft Corporation
  • Philips
  • Shimadzu Corporation
  •  Siemens Healthineers
  • Stryker Corporation
  • United Imaging Healthcare Co., Ltd.

Adjacent Markets

Single-cell Technologies Market
Live Cell Imaging Market
Infusion Pumps Market
Enteral Feeding Pumps Market
X-linked Hypophosphatemia (XLH) Market
Tumor-induced Osteomalacia (TIO) Drugs Market
1. Executive Summary
2. Global Lymphoedema Diagnostics Market Introduction
2.1. Global Lymphoedema Diagnostics Market – Taxonomy
2.2. Global Lymphoedema Diagnostics Market –Definitions
2.2.1. By Technology
2.2.2. By Disease Type
2.2.3. By End User
2.2.4. By Region
3. Global Lymphoedema Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Lymphoedema Diagnostics Market Dynamic Factors - Impact Analysis
3.6. Global Lymphoedema Diagnostics Market – Competition Landscape
4. Global Lymphoedema Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Lymphoedema Diagnostics Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. X-ray Lymphography
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Lymphoscintigraphy
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Computed Tomography
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Ultrasound Imaging
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Magnetic Resonance Imaging.
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Bioimpedance Analysis
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Near-infrared Fluorescence Imaging
5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. ICG Lymphography
5.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Fluorescein Sodium Microlymphangiography
5.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. Global Lymphoedema Diagnostics Market Forecast, By Disease Type, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Cancer
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Cardiovascular Disease
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Inflammatory Diseases
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Other Diseases
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Lymphoedema Diagnostics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Hospitals
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Diagnostic Centers
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Research & Academic Institutes
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Other End Users
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Lymphoedema Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Lymphoedema Diagnostics Market - Opportunity Analysis Index, By Technology, By Disease Type, End User, and Region, 2022-2028
9. North America Lymphoedema Diagnostics MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. X-ray Lymphography
9.1.2. Lymphoscintigraphy
9.1.3. Computed Tomography
9.1.4. Ultrasound Imaging
9.1.5. Magnetic Resonance Imaging
9.1.6. Bioimpedance Analysis
9.1.7. Near-infrared Fluorescence Imaging
9.1.8. ICG Lymphography
9.1.9. Fluorescein Sodium Microlymphangiography
9.2. By Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Cancer
9.2.2. Cardiovascular Disease
9.2.3. Inflammatory Diseases
9.2.4. Other Diseases
9.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Research & Academic Institutes
9.3.4. Other End Users
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Lymphoedema Diagnostics Market - Opportunity Analysis Index, By Technology, By Disease Type, End User, and Country, 2022-2028
9.6. North America Lymphoedema Diagnostics Market Dynamics – Trends
10. Europe Lymphoedema Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. X-ray Lymphography
10.1.2. Lymphoscintigraphy
10.1.3. Computed Tomography
10.1.4. Ultrasound Imaging
10.1.5. Magnetic Resonance Imaging
10.1.6. Bioimpedance Analysis
10.1.7. Near-infrared Fluorescence Imaging
10.1.8. ICG Lymphography
10.1.9. Fluorescein Sodium Microlymphangiography
10.2. By Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Cancer
10.2.2. Cardiovascular Disease
10.2.3. Inflammatory Diseases
10.2.4. Other Diseases
10.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Research & Academic Institutes
10.3.4. Other End Users
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Lymphoedema Diagnostics Market - Opportunity Analysis Index, By Technology, By Disease Type, End User, and Country, 2022-2028
10.6. Europe Lymphoedema Diagnostics Market Dynamics – Trends
11. Asia-Pacific Lymphoedema Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. X-ray Lymphography
11.1.2. Lymphoscintigraphy
11.1.3. Computed Tomography
11.1.4. Ultrasound Imaging
11.1.5. Magnetic Resonance Imaging
11.1.6. Bioimpedance Analysis
11.1.7. Near-infrared Fluorescence Imaging
11.1.8. ICG Lymphography
11.1.9. Fluorescein Sodium Microlymphangiography
11.2. By Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Cancer
11.2.2. Cardiovascular Disease
11.2.3. Inflammatory Diseases
11.2.4. Other Diseases
11.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Research & Academic Institutes
11.3.4. Other End Users
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Lymphoedema Diagnostics Market - Opportunity Analysis Index, By Technology, By Disease Type, End User, and Country, 2022-2028
11.6. Asia-Pacific Lymphoedema Diagnostics Market Dynamics – Trends
12. Latin America Lymphoedema Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. X-ray Lymphography
12.1.2. Lymphoscintigraphy
12.1.3. Computed Tomography
12.1.4. Ultrasound Imaging
12.1.5. Magnetic Resonance Imaging
12.1.6. Bioimpedance Analysis
12.1.7. Near-infrared Fluorescence Imaging
12.1.8. ICG Lymphography
12.1.9. Fluorescein Sodium Microlymphangiography
12.2. By Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Cancer
12.2.2. Cardiovascular Disease
12.2.3. Inflammatory Diseases
12.2.4. Other Diseases
12.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Research & Academic Institutes
12.3.4. Other End Users
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico